Ear Nose Throat J:空鼻综合症患者与慢性鼻窦炎和过敏性鼻炎患者的压力比较

2019-07-18 AlexYang MedSci原创

抑郁是一种越来越严重的公共精神健康疾病,因为抑郁不仅影响人们的日常生活,而且还与工作效率的减少相关。由其他疾病或者物质引起的抑郁称之为继发性抑郁症。在继发性抑郁症中,通过治愈潜在的病因就能够调节抑郁的情绪,这与抑郁症具有很大的不同。空鼻综合症(ENS)的主要症状为呼吸困难,尽管鼻子中具有足够的呼吸空间。研究人员发现ENS具有发展为抑郁情绪的倾向,并逐步增强导致具有自杀的倾向。因此,研究人员调查了E

抑郁是一种越来越严重的公共精神健康疾病,因为抑郁不仅影响人们的日常生活,而且还与工作效率的减少相关。由其他疾病或者物质引起的抑郁称之为继发性抑郁症。在继发性抑郁症中,通过治愈潜在的病因就能够调节抑郁的情绪,这与抑郁症具有很大的不同。空鼻综合症(ENS)的主要症状为呼吸困难,尽管鼻子中具有足够的呼吸空间。研究人员发现ENS具有发展为抑郁情绪的倾向,并逐步增强导致具有自杀的倾向。因此,研究人员调查了ENS患者的精神负担情况。

研究人员将患者分成4个组:ENS组(组A)、具有鼻息肉的慢性鼻窦炎组(组B)、不具有鼻息肉的慢性鼻窦炎组(组C)和过敏性鼻炎组(组D)。研究人员评估和比较了4个小组支架的白氏抑郁症量表(BDI)评分情况,并调查了ENS患者中抑郁症指数与鼻腔面积的关系。研究发现,ENS组抑郁的患病率为71%,并且严重度不同,该比例比组B(19%)、组C(15%)和组D(27%)显著更高。另外,ENS组中鼻腔体积与BDI评分的相关性不具有统计学显著性。

最后,研究人员指出,抑郁程度和严重度在ENS患者中要比CRS和AR患者更高。因此,医生应该对ENS患者的精神健康给予关注。

原始出处:


本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1661549, encodeId=c4c516615498d, content=<a href='/topic/show?id=aea3131932d' target=_blank style='color:#2F92EE;'>#OAT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13193, encryptionId=aea3131932d, topicName=OAT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37ad25322582, createdName=12498561m40(暂无昵称), createdTime=Sun Jan 19 16:36:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047137, encodeId=86aa204e13750, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Fri Jun 19 20:36:00 CST 2020, time=2020-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1351401, encodeId=fab913514017d, content=<a href='/topic/show?id=be7453e38d2' target=_blank style='color:#2F92EE;'>#慢性鼻窦炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53738, encryptionId=be7453e38d2, topicName=慢性鼻窦炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Jul 20 14:36:00 CST 2019, time=2019-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369930, encodeId=787a3699309d, content=有用,很赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ByYWdm8ibDZQnzFTp8VC0WgQ6IBLQ2iaaSlWs9ref9Hpz9sIz4skObwWyOw8jUMOgCibclJ07c02vsNap29icVuRZg/132, createdBy=1c612510072, createdName=LXLan, createdTime=Fri Jul 19 08:56:53 CST 2019, time=2019-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369922, encodeId=052a36992287, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Fri Jul 19 07:11:11 CST 2019, time=2019-07-19, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1661549, encodeId=c4c516615498d, content=<a href='/topic/show?id=aea3131932d' target=_blank style='color:#2F92EE;'>#OAT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13193, encryptionId=aea3131932d, topicName=OAT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37ad25322582, createdName=12498561m40(暂无昵称), createdTime=Sun Jan 19 16:36:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047137, encodeId=86aa204e13750, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Fri Jun 19 20:36:00 CST 2020, time=2020-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1351401, encodeId=fab913514017d, content=<a href='/topic/show?id=be7453e38d2' target=_blank style='color:#2F92EE;'>#慢性鼻窦炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53738, encryptionId=be7453e38d2, topicName=慢性鼻窦炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Jul 20 14:36:00 CST 2019, time=2019-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369930, encodeId=787a3699309d, content=有用,很赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ByYWdm8ibDZQnzFTp8VC0WgQ6IBLQ2iaaSlWs9ref9Hpz9sIz4skObwWyOw8jUMOgCibclJ07c02vsNap29icVuRZg/132, createdBy=1c612510072, createdName=LXLan, createdTime=Fri Jul 19 08:56:53 CST 2019, time=2019-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369922, encodeId=052a36992287, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Fri Jul 19 07:11:11 CST 2019, time=2019-07-19, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1661549, encodeId=c4c516615498d, content=<a href='/topic/show?id=aea3131932d' target=_blank style='color:#2F92EE;'>#OAT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13193, encryptionId=aea3131932d, topicName=OAT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37ad25322582, createdName=12498561m40(暂无昵称), createdTime=Sun Jan 19 16:36:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047137, encodeId=86aa204e13750, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Fri Jun 19 20:36:00 CST 2020, time=2020-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1351401, encodeId=fab913514017d, content=<a href='/topic/show?id=be7453e38d2' target=_blank style='color:#2F92EE;'>#慢性鼻窦炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53738, encryptionId=be7453e38d2, topicName=慢性鼻窦炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Jul 20 14:36:00 CST 2019, time=2019-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369930, encodeId=787a3699309d, content=有用,很赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ByYWdm8ibDZQnzFTp8VC0WgQ6IBLQ2iaaSlWs9ref9Hpz9sIz4skObwWyOw8jUMOgCibclJ07c02vsNap29icVuRZg/132, createdBy=1c612510072, createdName=LXLan, createdTime=Fri Jul 19 08:56:53 CST 2019, time=2019-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369922, encodeId=052a36992287, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Fri Jul 19 07:11:11 CST 2019, time=2019-07-19, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1661549, encodeId=c4c516615498d, content=<a href='/topic/show?id=aea3131932d' target=_blank style='color:#2F92EE;'>#OAT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13193, encryptionId=aea3131932d, topicName=OAT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37ad25322582, createdName=12498561m40(暂无昵称), createdTime=Sun Jan 19 16:36:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047137, encodeId=86aa204e13750, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Fri Jun 19 20:36:00 CST 2020, time=2020-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1351401, encodeId=fab913514017d, content=<a href='/topic/show?id=be7453e38d2' target=_blank style='color:#2F92EE;'>#慢性鼻窦炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53738, encryptionId=be7453e38d2, topicName=慢性鼻窦炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Jul 20 14:36:00 CST 2019, time=2019-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369930, encodeId=787a3699309d, content=有用,很赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ByYWdm8ibDZQnzFTp8VC0WgQ6IBLQ2iaaSlWs9ref9Hpz9sIz4skObwWyOw8jUMOgCibclJ07c02vsNap29icVuRZg/132, createdBy=1c612510072, createdName=LXLan, createdTime=Fri Jul 19 08:56:53 CST 2019, time=2019-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369922, encodeId=052a36992287, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Fri Jul 19 07:11:11 CST 2019, time=2019-07-19, status=1, ipAttribution=)]
    2019-07-19 LXLan

    有用,很赞

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1661549, encodeId=c4c516615498d, content=<a href='/topic/show?id=aea3131932d' target=_blank style='color:#2F92EE;'>#OAT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13193, encryptionId=aea3131932d, topicName=OAT)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37ad25322582, createdName=12498561m40(暂无昵称), createdTime=Sun Jan 19 16:36:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2047137, encodeId=86aa204e13750, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Fri Jun 19 20:36:00 CST 2020, time=2020-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1351401, encodeId=fab913514017d, content=<a href='/topic/show?id=be7453e38d2' target=_blank style='color:#2F92EE;'>#慢性鼻窦炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53738, encryptionId=be7453e38d2, topicName=慢性鼻窦炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Jul 20 14:36:00 CST 2019, time=2019-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369930, encodeId=787a3699309d, content=有用,很赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ByYWdm8ibDZQnzFTp8VC0WgQ6IBLQ2iaaSlWs9ref9Hpz9sIz4skObwWyOw8jUMOgCibclJ07c02vsNap29icVuRZg/132, createdBy=1c612510072, createdName=LXLan, createdTime=Fri Jul 19 08:56:53 CST 2019, time=2019-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369922, encodeId=052a36992287, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Fri Jul 19 07:11:11 CST 2019, time=2019-07-19, status=1, ipAttribution=)]
    2019-07-19 飛歌

    学习了很有用不错

    0

相关资讯

“感觉剥夺”与空鼻综合症(ENS)

1954年,加拿大麦克吉尔大学的心理学家柏克森与他的同事进行了一场“感觉剥夺”实验:实验中给被试者戴上半透明的护目镜,使其难以产生视觉;用空气调节器发出的单调声音限制其听觉;手臂戴上纸筒套袖和手套,腿脚用夹板固定,被试单独呆在实验室里,几小时后开始感到恐慌……在实验室连续呆了三四天后,被试者产生出现错觉幻觉,注意力涣散,思维迟钝,紧张、焦虑、恐惧,对痛觉敏感等。实验后数日被试者才能逐渐恢复正常。